Published in TB and Outbreaks Week, November 7th, 2006
"Patients were categorized into ART+ group (received ART) and ART-group (did not receive ART) and were followed until April 2005. A...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.